Search Results

Parkinson's disease: the genetics of a heterogeneous disorder.

• Authors : Gosal, D.; Ross, O. A.; Toft, M.

Subjects: PARKINSON'S disease & genetics; BRAIN diseases; EXTRAPYRAMIDAL disorders

• Source: European Journal of Neurology; Jun2006, Vol. 13 Issue 6, p616-627, 12p, 7 Color Photographs, 2 Diagrams, 1 Chart

Record details

Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson's disease

• Authors : Horstink, M.; Tolosa, E.; Bonuccelli, U.

Subjects: PARKINSON'S disease; DRUG therapy; DISEASES -- Management

• Source: European Journal of Neurology; Nov2006, Vol. 13 Issue 11, p1186-1202, 17p

Record details

Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies and the Movement Disorder Society–European Section. Part I: early (uncomplicated) Parkinson's disease.

• Authors : Horstink, M.; Tolosa, E.; Bonuccelli, U.

Subjects: PARKINSON'S disease; DRUG therapy; PHYSICAL therapy

• Source: European Journal of Neurology; Nov2006, Vol. 13 Issue 11, p1170-1185, 16p

Record details

Constant dopaminergic stimulation by transdermal delivery of dopaminergic drugs: a new treatment paradigm in Parkinson's disease.

• Authors : Steiger, M.

Subjects: DOPAMINE receptors; PARKINSON'S disease; CLINICAL trials

• Source: European Journal of Neurology; Jan2008, Vol. 15 Issue 1, p2-11, 10p, 2 Charts, 1 Graph

Record details

Controlling the mass action of α-synuclein in Parkinson’s disease.

• Authors : Changyoun Kim; Seung-Jae Lee

Subjects: PARKINSON'S disease; NEURODEGENERATION; POLYPEPTIDES

• Source: Journal of Neurochemistry; Oct2008, Vol. 107 Issue 2, p303-316, 14p, 2 Diagrams

Record details

Dopamine agonists in the treatment of non-motor symptoms of Parkinson’s disease: depression.

• Authors : Lemke, M. R.

Subjects: DOPAMINE agonists; PARKINSON'S disease; MENTAL depression

• Source: European Journal of Neurology; Apr2008 Supplement 2, Vol. 15, p9-14, 6p, 1 Chart, 3 Graphs

Record details

The tolerability and efficacy of entacapone over 3 years in patients with Parkinson's disease.

• Authors : Larsen, J. P.; Worm-Petersen, J.; Sidén, Å.

Subjects: ENTACAPONE; PARKINSON'S disease patients

• Source: European Journal of Neurology; Mar2003, Vol. 10 Issue 2, p137-146, 10p

Record details

Acquired temperature-sensitive paralysis as a biomarker of declining neuronal function in aging Drosophila.

• Authors : Reenan, Robert A.; Rogina, Blanka

Subjects: AGING; DROSOPHILA; PARALYSIS

• Source: Aging Cell; Apr2008, Vol. 7 Issue 2, p179-186, 8p, 1 Chart, 5 Graphs

Record details

Role of High-Affinity Dopamine Uptake and Impulse Activity in the Appearance of Extracellular Dopamine in Striatum After Administration of Exogenous L-DOPA.

• Authors : Miller, David W.; Abercrombie, Elizabeth D.

Subjects: DOPAMINE; DOPA; ANALYTICAL chemistry

• Source: Journal of Neurochemistry; Apr99, Vol. 72 Issue 4, p1516-1522, 7p, 5 Graphs

Record details

Investigators' Workshop Poster Session 11:30 a.m.-1:30 p.m.

Subjects: CONFERENCES & conventions; ASSOCIATIONS, institutions, etc.; SPASMS

• Source: Epilepsia (Series 4); Oct2007 Supplement 6, Vol. 48, p238-248, 11p, 2 Diagrams, 1 Chart, 1 Graph

Record details